Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
Chronic obstructive pulmonary disease: Combined inhaler proves effective Results from four in-depth studies show that a combined inhaler is very effective for treatment of moderate to severe chronic lung disease. Alleviating the symptoms of chronic obstructive pulmonary disease (COPD), particularly...
Guardado en:
Autores principales: | Gary T. Ferguson, Jill Karpel, Nathan Bennett, Emmanuelle Clerisme-Beaty, Lars Grönke, Florian Voß, Roland Buhl |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/406e40dbb4ce42a9aa38295481bd3e25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
por: Sandeep Bansal, et al.
Publicado: (2021) -
Work absence in patients with asthma and/or COPD: a population-based study
por: Boudewijn J. H. Dierick, et al.
Publicado: (2021) -
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Mònica Monteagudo, et al.
Publicado: (2021) -
Case-finding for COPD clinic acceptability to patients in GPs across Hampshire: a qualitative study
por: Danielle Rose, et al.
Publicado: (2021) -
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
por: Shuli Qu, et al.
Publicado: (2021)